Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 11 | 2022 | 104 | 4.260 |
Why?
|
| Stroke | 12 | 2019 | 340 | 2.660 |
Why?
|
| Brain Ischemia | 7 | 2020 | 189 | 2.280 |
Why?
|
| Longevity | 4 | 2024 | 173 | 1.710 |
Why?
|
| Hawaii | 25 | 2024 | 2011 | 1.490 |
Why?
|
| Brain Injuries | 4 | 2014 | 129 | 1.350 |
Why?
|
| Hypertension | 6 | 2024 | 835 | 1.300 |
Why?
|
| Hospitalization | 5 | 2024 | 485 | 1.160 |
Why?
|
| Pre-Eclampsia | 2 | 2019 | 67 | 1.040 |
Why?
|
| Retrospective Studies | 19 | 2024 | 2544 | 1.020 |
Why?
|
| Patient Readmission | 2 | 2018 | 122 | 0.940 |
Why?
|
| Middle Aged | 30 | 2024 | 12222 | 0.820 |
Why?
|
| Female | 38 | 2020 | 24698 | 0.820 |
Why?
|
| Humans | 51 | 2024 | 43102 | 0.800 |
Why?
|
| Male | 35 | 2024 | 23409 | 0.790 |
Why?
|
| Aged | 24 | 2024 | 8214 | 0.790 |
Why?
|
| Decompressive Craniectomy | 2 | 2011 | 2 | 0.690 |
Why?
|
| Aged, 80 and over | 13 | 2023 | 2853 | 0.650 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2020 | 3 | 0.650 |
Why?
|
| Cerebrovascular Circulation | 2 | 2011 | 70 | 0.640 |
Why?
|
| Adult | 21 | 2019 | 13872 | 0.610 |
Why?
|
| Hospital Costs | 1 | 2019 | 27 | 0.610 |
Why?
|
| Embolism, Paradoxical | 1 | 2019 | 2 | 0.600 |
Why?
|
| Foramen Ovale, Patent | 1 | 2019 | 4 | 0.600 |
Why?
|
| Patient Discharge | 4 | 2016 | 128 | 0.600 |
Why?
|
| Health Status Disparities | 3 | 2024 | 719 | 0.590 |
Why?
|
| Homeostasis | 2 | 2011 | 192 | 0.590 |
Why?
|
| Prevalence | 4 | 2017 | 1612 | 0.590 |
Why?
|
| Venous Thromboembolism | 1 | 2019 | 22 | 0.580 |
Why?
|
| Intracranial Hemorrhages | 2 | 2017 | 28 | 0.560 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 42 | 0.560 |
Why?
|
| Genotype | 4 | 2024 | 800 | 0.540 |
Why?
|
| Postpartum Hemorrhage | 1 | 2017 | 18 | 0.520 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 590 | 0.520 |
Why?
|
| Ossification of Posterior Longitudinal Ligament | 1 | 2016 | 1 | 0.510 |
Why?
|
| Quadriplegia | 1 | 2016 | 4 | 0.510 |
Why?
|
| Patient Transfer | 2 | 2019 | 25 | 0.480 |
Why?
|
| Social Work Department, Hospital | 1 | 2015 | 1 | 0.470 |
Why?
|
| Intracranial Hypertension | 2 | 2012 | 3 | 0.460 |
Why?
|
| Saline Solution, Hypertonic | 2 | 2012 | 8 | 0.460 |
Why?
|
| Air Ambulances | 1 | 2015 | 5 | 0.450 |
Why?
|
| International Normalized Ratio | 1 | 2014 | 9 | 0.450 |
Why?
|
| Withholding Treatment | 1 | 2015 | 30 | 0.450 |
Why?
|
| Blood Coagulation Factors | 1 | 2014 | 7 | 0.450 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 26 | 0.440 |
Why?
|
| Needs Assessment | 2 | 2015 | 178 | 0.430 |
Why?
|
| Risk Factors | 9 | 2024 | 3994 | 0.430 |
Why?
|
| Length of Stay | 2 | 2016 | 229 | 0.420 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 154 | 0.420 |
Why?
|
| Warfarin | 1 | 2014 | 67 | 0.420 |
Why?
|
| Anticoagulants | 1 | 2014 | 122 | 0.410 |
Why?
|
| Resuscitation Orders | 1 | 2013 | 7 | 0.410 |
Why?
|
| Family | 1 | 2015 | 195 | 0.400 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 235 | 0.390 |
Why?
|
| Central Nervous System Stimulants | 1 | 2015 | 180 | 0.390 |
Why?
|
| Methamphetamine | 1 | 2015 | 166 | 0.390 |
Why?
|
| Paresis | 2 | 2011 | 10 | 0.370 |
Why?
|
| Sex Factors | 4 | 2018 | 1028 | 0.360 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2011 | 1 | 0.360 |
Why?
|
| Attitude to Health | 1 | 2014 | 338 | 0.350 |
Why?
|
| Body Temperature | 1 | 2011 | 35 | 0.350 |
Why?
|
| Vasoconstriction | 1 | 2011 | 42 | 0.350 |
Why?
|
| Vasopressins | 1 | 2011 | 12 | 0.350 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2011 | 8 | 0.340 |
Why?
|
| Functional Laterality | 1 | 2011 | 89 | 0.340 |
Why?
|
| Prospective Studies | 4 | 2024 | 1600 | 0.340 |
Why?
|
| Organ Transplantation | 1 | 2011 | 24 | 0.340 |
Why?
|
| Young Adult | 8 | 2019 | 5080 | 0.340 |
Why?
|
| Parkinson Disease | 2 | 2024 | 210 | 0.330 |
Why?
|
| Registries | 1 | 2013 | 437 | 0.330 |
Why?
|
| Pregnancy | 4 | 2019 | 1772 | 0.320 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2016 | 21 | 0.320 |
Why?
|
| Obesity | 2 | 2014 | 1151 | 0.310 |
Why?
|
| Posterior Cerebral Artery | 1 | 2009 | 2 | 0.300 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 719 | 0.300 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2024 | 863 | 0.290 |
Why?
|
| Age Factors | 4 | 2016 | 1154 | 0.290 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 539 | 0.290 |
Why?
|
| Visual Cortex | 1 | 2009 | 64 | 0.290 |
Why?
|
| Meninges | 1 | 2008 | 6 | 0.290 |
Why?
|
| Prealbumin | 1 | 2008 | 8 | 0.290 |
Why?
|
| Eclampsia | 1 | 2008 | 12 | 0.280 |
Why?
|
| Threonine | 1 | 2008 | 24 | 0.280 |
Why?
|
| Caregivers | 3 | 2015 | 197 | 0.280 |
Why?
|
| Proline | 1 | 2008 | 40 | 0.280 |
Why?
|
| Amyloidosis | 1 | 2008 | 37 | 0.280 |
Why?
|
| Blood Pressure | 4 | 2011 | 666 | 0.260 |
Why?
|
| Odds Ratio | 3 | 2018 | 587 | 0.240 |
Why?
|
| Fibrinolytic Agents | 2 | 2016 | 24 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 245 | 0.230 |
Why?
|
| Coronary Artery Disease | 2 | 2024 | 163 | 0.210 |
Why?
|
| United States | 4 | 2019 | 5205 | 0.200 |
Why?
|
| Qualitative Research | 3 | 2015 | 574 | 0.200 |
Why?
|
| Mutation | 1 | 2008 | 1177 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 587 | 0.190 |
Why?
|
| Dementia, Vascular | 1 | 2023 | 35 | 0.190 |
Why?
|
| Alleles | 1 | 2023 | 352 | 0.190 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 80 | 0.180 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2011 | 9 | 0.180 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 138 | 0.170 |
Why?
|
| Rib Fractures | 1 | 2020 | 3 | 0.170 |
Why?
|
| Thoracic Injuries | 1 | 2020 | 11 | 0.170 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 15 | 0.170 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2020 | 30 | 0.170 |
Why?
|
| Middle Cerebral Artery | 2 | 2011 | 14 | 0.160 |
Why?
|
| Perfusion Imaging | 1 | 2020 | 1 | 0.160 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 3156 | 0.150 |
Why?
|
| Brain | 3 | 2012 | 1472 | 0.150 |
Why?
|
| Thrombolytic Therapy | 2 | 2016 | 23 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2019 | 341 | 0.140 |
Why?
|
| Time Factors | 3 | 2020 | 1857 | 0.130 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 65 | 0.130 |
Why?
|
| Skull Fractures | 1 | 2017 | 4 | 0.130 |
Why?
|
| Recovery of Function | 2 | 2016 | 107 | 0.130 |
Why?
|
| Drug Costs | 1 | 2017 | 35 | 0.130 |
Why?
|
| Cerebral Revascularization | 2 | 2019 | 3 | 0.130 |
Why?
|
| Delivery, Obstetric | 1 | 2017 | 48 | 0.130 |
Why?
|
| Survivors | 2 | 2014 | 152 | 0.120 |
Why?
|
| Age of Onset | 1 | 2016 | 114 | 0.120 |
Why?
|
| Glasgow Coma Scale | 2 | 2013 | 21 | 0.120 |
Why?
|
| Hospital Mortality | 1 | 2018 | 210 | 0.120 |
Why?
|
| After-Hours Care | 1 | 2016 | 4 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 89 | 0.120 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2016 | 14 | 0.120 |
Why?
|
| Comorbidity | 2 | 2018 | 737 | 0.120 |
Why?
|
| Minority Health | 1 | 2016 | 95 | 0.120 |
Why?
|
| Nurse Practitioners | 1 | 2016 | 24 | 0.120 |
Why?
|
| Treatment Outcome | 4 | 2016 | 1604 | 0.120 |
Why?
|
| Telemedicine | 1 | 2019 | 234 | 0.120 |
Why?
|
| Economics, Hospital | 1 | 2015 | 9 | 0.120 |
Why?
|
| Intracranial Pressure | 2 | 2012 | 5 | 0.120 |
Why?
|
| Budgets | 1 | 2015 | 15 | 0.120 |
Why?
|
| Professional-Patient Relations | 1 | 2015 | 60 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 1001 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2014 | 60 | 0.110 |
Why?
|
| Transportation of Patients | 1 | 2014 | 14 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 60 | 0.110 |
Why?
|
| Pacific Islands | 1 | 2015 | 123 | 0.110 |
Why?
|
| Coma | 1 | 2014 | 7 | 0.110 |
Why?
|
| Disease Progression | 1 | 2017 | 667 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 287 | 0.110 |
Why?
|
| Heart Arrest | 1 | 2014 | 52 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2017 | 863 | 0.100 |
Why?
|
| Insurance, Health | 1 | 2014 | 145 | 0.100 |
Why?
|
| Glasgow Outcome Scale | 1 | 2013 | 5 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 2 | 2012 | 125 | 0.090 |
Why?
|
| Radiography | 1 | 2012 | 71 | 0.090 |
Why?
|
| Fluid Therapy | 1 | 2012 | 29 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 638 | 0.090 |
Why?
|
| Social Support | 1 | 2015 | 445 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1124 | 0.090 |
Why?
|
| Blood Flow Velocity | 1 | 2011 | 87 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 53 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2014 | 363 | 0.090 |
Why?
|
| Diuretics, Osmotic | 1 | 2011 | 4 | 0.090 |
Why?
|
| Models, Biological | 1 | 2014 | 712 | 0.090 |
Why?
|
| Brain Death | 1 | 2011 | 8 | 0.090 |
Why?
|
| Mannitol | 1 | 2011 | 11 | 0.090 |
Why?
|
| Fever | 1 | 2011 | 62 | 0.090 |
Why?
|
| Coronary Angiography | 1 | 2011 | 96 | 0.090 |
Why?
|
| Hypotension | 1 | 2011 | 24 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 39 | 0.090 |
Why?
|
| Heart Rupture | 1 | 2010 | 1 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2011 | 100 | 0.080 |
Why?
|
| Incidence | 2 | 2024 | 1078 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2014 | 925 | 0.080 |
Why?
|
| Nervous System | 1 | 2010 | 32 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 66 | 0.080 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2012 | 92 | 0.080 |
Why?
|
| Disability Evaluation | 1 | 2010 | 73 | 0.080 |
Why?
|
| Quality of Life | 1 | 2014 | 616 | 0.080 |
Why?
|
| Vascular Resistance | 1 | 2009 | 36 | 0.070 |
Why?
|
| Vision, Ocular | 1 | 2009 | 43 | 0.070 |
Why?
|
| Vasodilation | 1 | 2009 | 64 | 0.070 |
Why?
|
| Infant | 1 | 2012 | 1175 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 95 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2008 | 68 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1285 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2009 | 185 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2012 | 1546 | 0.070 |
Why?
|
| Heart Rate | 1 | 2009 | 266 | 0.070 |
Why?
|
| Prognosis | 3 | 2017 | 861 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 749 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 497 | 0.060 |
Why?
|
| Japan | 1 | 2024 | 348 | 0.050 |
Why?
|
| Infusions, Intravenous | 2 | 2016 | 53 | 0.050 |
Why?
|
| Adolescent | 1 | 2014 | 6081 | 0.050 |
Why?
|
| Prescriptions | 1 | 2021 | 19 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2020 | 92 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1063 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2019 | 142 | 0.040 |
Why?
|
| Lovastatin | 1 | 2017 | 9 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2017 | 98 | 0.030 |
Why?
|
| Simvastatin | 1 | 2017 | 29 | 0.030 |
Why?
|
| Aging | 1 | 2022 | 783 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 223 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 179 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2014 | 24 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 359 | 0.030 |
Why?
|
| Medicare | 1 | 2017 | 332 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 440 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2014 | 452 | 0.020 |
Why?
|
| Neurology | 1 | 2012 | 12 | 0.020 |
Why?
|
| Cardiology | 1 | 2012 | 18 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2012 | 16 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 44 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 55 | 0.020 |
Why?
|
| Seizures | 1 | 2012 | 79 | 0.020 |
Why?
|
| Forecasting | 1 | 2012 | 136 | 0.020 |
Why?
|
| Calibration | 1 | 2011 | 63 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2010 | 78 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 317 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 375 | 0.020 |
Why?
|
| Myocardium | 1 | 2010 | 263 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1759 | 0.020 |
Why?
|
| Animals | 1 | 2022 | 16992 | 0.010 |
Why?
|